A Phase 2a clinical trial of Molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus
William A. Fischer
◽
Joseph J. Eron
◽
Wayne Holman
◽
Myron S. Cohen
◽
Lei Fang
◽
...
2004 ◽
Vol 29
(2-3)
◽
pp. 195-199
◽
Eric Romanowski
◽
Stephen Bartels
◽
Roger Vogel
◽
Neal Wetherall
◽
Cheryl Hodges-Savola
◽
...
1966 ◽
Vol 195
(7)
◽
pp. 586-588
2002 ◽
Vol 89
(2)
◽
pp. 154-157
◽
F. F Palazzo
◽
D. L Francis
◽
M. A Clifton
1998 ◽
Vol 23
(4)
◽
pp. 374-374
2012 ◽
Vol 2012
◽
pp. 106-107
2001 ◽
Vol 120
(5)
◽
pp. A25-A25
◽
R DELCENSERIE
◽
M PAGENAULT
◽
P HASTIER
◽
T YZET
2001 ◽
Vol 120
(5)
◽
pp. A453-A453
◽
B SHEN
◽
J ACHKAR
◽
B LASHNER
◽
A ORMSBY
◽
F REMZI
◽
...
2007 ◽
Vol 177
(4S)
◽
pp. 433-434
Narmada P. Gupta
◽
Anup Kumar
◽
Ashok K. Hemal
◽
Pankaj Wadhwa
2006 ◽
Vol 175
(4S)
◽
pp. 109-109
Sero Andonian
◽
Benoit St-Denis
◽
Marie-Claude Lemieux
◽
Jacques Corcos
2006 ◽
Vol 39
(12)
◽
pp. 41